We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$155M
AUM Growth
-$49.7M
Cap. Flow
-$68.5M
Cap. Flow %
-44.26%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
BVS icon
Bioventus
BVS
+$22.5M

Top Sells

Rank Stock Value
1
MSON
Misonix Inc
MSON
+$42.9M
2
BCYC
Bicycle Therapeutics
BCYC
+$28.6M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$15.3M
4
RGEN icon
Repligen
RGEN
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
1
Bicycle Therapeutics
BCYC
$303M
$55.9M 36.13%
918,154
-518,302
-36% -$28.6M
AHCO icon
2
AdaptHealth
AHCO
$774M
$47.5M 30.69%
1,941,118
– –
STRO icon
3
Sutro Biopharma
STRO
$353M
$27.1M 17.55%
182,454
– –
BVS icon
4
Bioventus
BVS
$942M
$22.9M 14.81%
+1,581,031
New +$22.5M
XFOR icon
5
X4 Pharmaceuticals
XFOR
$419M
$713K 0.46%
10,383
– –
ASXC
6
DELISTED
Asensus Surgical, Inc.
ASXC
$566K 0.37%
510,142
– –
RGEN icon
7
Repligen
RGEN
$10.3B
– –
-14,541
Closed -$4.2M
DCPH
8
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-449,951
Closed -$15.3M
MSON
9
DELISTED
Misonix Inc
MSON
– –
-1,694,017
Closed -$42.9M

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q4 2021 Portfolio in Review

As of Q4 2021, SV Health Investors held 9 positions worth $155M, down 24% from $204M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $68.5M in Q4 2021, closing 3 positions and reducing 1 holding. Its most notable exit was Misonix Inc, an estimated $42.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, SV Health Investors opened a new position in Bioventus worth $22.9M.

  • SV Health Investors's largest Q4 2021 buy was Bioventus: 1,581,031 shares worth $22.9M.
  • SV Health Investors's biggest Q4 2021 reduction was Bicycle Therapeutics, cutting an estimated $28.6M.
  • SV Health Investors fully exited Misonix Inc in Q4 2021, selling an estimated $42.9M.
  • SV Health Investors's ten largest holdings make up 100% of its $155M portfolio in Q4 2021.
  • SV Health Investors opened 1 new position and closed 3 in Q4 2021.
  • SV Health Investors's portfolio value fell 24% quarter-over-quarter to $155M.

Based on SV Health Investors's 13F filing for Q4 2021, filed 11 Feb 2022.